IMA · NASDAQ · Biotechnology

ImageneBio (IMA)

Develops IMG-007 for autoimmune and inflammatory diseases.

$5.01
At close−0.01 (−0.20%)

Something off on this page? Send us feedback.

Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.83
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.18−$0.18−$0.06−$2.91−$0.62−$0.95−$0.63Pending
Estimate−$0.19−$0.21−$0.14−$1.47−$1.45−$0.70−$0.98−$0.83
Surprise+5.3%+14.3%+57.1%−98.0%+57.2%−35.7%+35.5%

RevenueReportedEstimate

Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
ReportedPending
Estimate$875.0K
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$0.83
Aug 2026−$0.98
Aug 2026−$0.98−$0.63+35.5%
May 2026−$0.70−$0.95−35.7%
Mar 2026−$1.45−$0.62+57.2%
Nov 2025−$1.47−$2.91−98.0%

The latest year is open to everyone — the 23 quarters behind it read with an account.

Sign in
Jul 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Dec 2020
Jun 2020
Mar 2020
Dec 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 11, 2026−$0.83
Aug 6, 2026−$0.98
Aug 5, 2026−$0.98−$0.63+35.5%+0.7%
May 7, 2026−$0.70−$0.95−35.7%−10.5%
Mar 10, 2026−$1.45−$0.62+57.2%−1.0%
Nov 12, 2025−$1.47−$2.91−98.0%−2.6%

The latest year is open to everyone — the 23 quarters behind it read with an account.

Sign in
Jul 24, 2025
May 8, 2025
Mar 6, 2025
Nov 7, 2024
Aug 8, 2024
May 13, 2024
Mar 12, 2024
Nov 9, 2023
Aug 10, 2023
May 15, 2023
Mar 14, 2023
Nov 7, 2022
Aug 11, 2022
May 12, 2022
Mar 17, 2022
Nov 10, 2021
Aug 12, 2021
May 13, 2021
Mar 26, 2021
Dec 31, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019